TSX:WEED (Canopy Growth)
About WEED
Canopy Growth Corp. engages in the production and sale of medical cannabis. The firm operates through the following segments: Global Cannabis and Other Consumer Products. The Global Cannabis segment encompasses the production, distribution and sale of a diverse range of cannabis and cannabinoid-based consumer products in Canada and internationally pursuant to applicable international and domestic legislation, regulations and permits. The Other Consumer Products segment encompasses the production, distribution and sale of consumer products by Storz & Bickel, This Works, BioSteel, and other ancillary revenue sources. It focuses on the treatment of chronic pain, seizures, muscle spasms, nausea, and loss of appetite. The company was founded by Bruce Linton on August 5, 2009 and is headquartered in Smith Falls, Canada.
Canopy Growth (TSX: WEED) Latest News

Cannabis Stocks
Why Canopy Growth (TSX:WEED) Stock Jumped on Thursday

Tech Stocks
Under Fire: 2 High-Profile TSX Stocks to Avoid in Q4 2021

Cannabis Stocks
TSX Stocks Trading Near 52-Week Lows

Cannabis Stocks
What Does the SAFE Banking Act Mean for Pot Stocks in 2021?

Tech Stocks
These 4 Canadian Stocks Have Corrected Over 10% in September: Should You Buy?

Cannabis Stocks
Cannabis Selloff: 3 Weed Stocks to Avoid and 1 Must-Buy

Cannabis Stocks
If Cannabis Stocks Are Out of Favour, Is Now the Time to Buy?

Cannabis Stocks
3 Cannabis Stocks to Buy Before the Next Boom

Metals and Mining Stocks
3 TSX 60 Components Down Over 20% in 2021

Energy Stocks
3 Cheap Canadian Stocks to Buy Right Now

Cannabis Stocks
Stock Markets to Recover Tuesday: Will a Beaten-Down Canopy Growth Stock Recover, Too?
